StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SOKE.IS$18.50+0.00%
Fair $18.50+0.0%

SOKE.IS

Söke Degirmencilik Sanayi ve Ticaret A.S.

Consumer Defensive / Packaged FoodsIstanbul

$18.50

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $18.50Fund rank 30/100 · Data gapFallback financials|
SA 40/C
F-Score: 4/9
Margin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-670.0M · quality 55.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Operating margin has declined for 3 consecutive years ROE is -8.6%, below the 5% threshold
Thesis & Journal · SOKE.ISLocal privado en este navegador · Söke Degirmencilik Sanayi ve Ticaret A.S.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$7.2B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-8.6%

↓

Gross Margin

7.6%

↓

Debt/Equity

0.13

↓
52-Week Range$19
$10$21

TradingView lightweight chart

SOKE.IS price, volumen y niveles de valoración

Último $18.75Periodo +127.3%
Fair value: $18.50

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+16.8%

FCF CAGR

—

FCF margin

-1.1%

FCF / Net income

0.24x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.54B · net income $-339.3M · FCF $-83.0M

2022-FY → 2025-FY

Gross margin

7.6%-7.2% pts

Operating margin

0.2%-9.7% pts

Net margin

-4.5%-11.0% pts

FCF margin

-1.1%-4.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$7.54B$7.54B$7.15B$7.57B$4.73B
Net Income$-339.3M$-339.3M$-330.0M$-141.2M$308.0M
EBITDA$-37.8M$-37.8M$9.6M$195.5M$473.3M
EPS-0.88-0.88-0.85-0.400.80
Gross Margin7.6%7.6%11.3%14.1%14.8%
Operating Margin0.2%0.2%2.4%7.7%9.9%
Net Margin-4.5%-4.5%-4.6%-1.9%6.5%
Balance Sheet
Debt/Equity0.130.130.150.010.15
Current Ratio1.551.55———
Cash Flow
Free Cash Flow$-83.0M$-83.0M$-670.0M$-905.4M$136.4M
Returns
ROE-8.6%-8.6%-7.4%-4.1%19.0%
Valuation
EV/EBITDA——493.3530.18—
P/B1.811.811.091.89—
Growth & Yield
Revenue Growth5.4%5.4%-5.5%60.0%—
EPS Growth-3.5%-3.5%-112.5%-150.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +77.6%

Total return

+77.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.85 → -0.88

Residual

+77.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+77.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.